Alnylam Pharmaceuticals
ALNY
#652
Rank
A$54.99 B
Marketcap
A$411.91
Share price
-0.48%
Change (1 day)
-8.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company